| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |